Literature DB >> 27233620

Protein expression profiling in haemocytes and plasma of the Manila clam Ruditapes philippinarum in response to infection with Perkinsus olseni.

S Fernández-Boo1, A Villalba2,3, A Cao1.   

Abstract

The protein expression profiling in clam haemocytes and plasma in response to Perkinsus olseni was addressed. Adult Manila clams from a P. olseni-free bed were experimentally challenged with parasite zoospores to analyse immune response. In another experiment, the effects of longer term infection were assessed in adult clams collected from a P. olseni-affected bed, by comparing moderate to very heavily infected clams with non-infected ones. Haemocyte and plasma proteins were separated by two-dimensional electrophoresis; spot patterns were qualitatively compared between treatments within each experiment and the spots indicating differential protein expression associated with P. olseni challenge or with field infection were processed for protein identification. Fifteen clam proteins (four in haemocytes and eleven in plasma) of which expression was markedly affected by P. olseni were identified. Some of the identified proteins have a well-known role in clam immune response against the parasite, such as lysozyme and lectins. Rho GTPase-activating protein 6 could be a marker of resistance against P. olseni, which should be further studied.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  ankyrin; integrin; lectins; lysozyme; rho GTPase; transcriptional regulator ATRX

Mesh:

Substances:

Year:  2016        PMID: 27233620     DOI: 10.1111/jfd.12470

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  1 in total

1.  Identification of immune-related proteins of Dreissena polymorpha hemocytes and plasma involved in host-microbe interactions by differential proteomics.

Authors:  Maxime Leprêtre; Christine Almunia; Jean Armengaud; Antoine Le Guernic; Arnaud Salvador; Alain Geffard; Mélissa Palos-Ladeiro
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.